The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mathiesen Jeffrey S since year 2005.
The trader's CIK number is 1296853.
At the time of this reporting, Mathiesen Jeffrey S is the Chief Financial Officer of Gemphire Therapeutics Inc. .
(stock ticker symbol GEMP).
See this page for all insider trading activities at Gemphire Therapeutics Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-08-14||GEMP||Gemphire Therapeutics Inc.||Option Ex||3,207||3.59||11,513|
|2017-08-10||GEMP||Gemphire Therapeutics Inc.||Option Ex||3,000||3.59||10,770|
|2016-08-10||GEMP||Gemphire Therapeutics Inc.||Buy||4,000||10.00||40,000|
|2014-03-17||SSH||Sunshine Heart, Inc.||Buy||2,000||6.18||12,360|
|2008-11-13||ZRBA||Zareba Systems Inc||Buy||2,268||1.36||3,084|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mathiesen Jeffrey S (Chief Financial Officer of Gemphire Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.